Inhibitory RNAs to RNA binding proteins hnRNPA1, hnRNPA2 and PTB and uses thereof

Targeted particles comprising landscape phage fusion proteins and heterologous nucleic acid

RNA sequence-specific mediators of RNA interference

Use of a growth-stimulating protein

Agent for suppressing expression of dominant mutant gene

Inhibition of PCSK9 through RNAi

Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereof

Method of producing dicer

MCPIP PROTECTION AGAINST OSTEOCLAST PRODUCTION

Method of regulating gene expression

Method for producing novel hiPSC by means of miRNA introduction

Method for modulating double-strand break-induced homologous recombination

Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (TIx)

Method to trigger RNA interference

Method for producing novel hipsc by means of siRNA introduction

Growth factor isoform

Compositions and methods for inhibiting expression of mutant EGFR gene

TREATMENT OF HEPATOCYTE GROWTH FACTOR (HGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO HGF

Dual targeting siRNA agents

Graft copolymer polyelectrolyte complexes for drug delivery

Inhibitor of HMGB protein-mediated immune response activation, and screening method

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

In vivo gene silencing by chemically modified and stable siRNA

Cancer cell identification marker and cancer cell proliferation inhibitor

Selective inhibition of polyglutamine protein expression

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

Methods and compositions for prevention or treatment of RSV infection

Invertebrate microRNAs

Method and medicament for inhibiting the expression of a given gene

Single use system for sterilely producing lipid-nucleic acid particles

Regulators of NFAT and/or store-operated calcium entry

Compositions and methods directed to treating liver fibrosis

Insulin-resistance-improving drug

Compositions and methods for treating cancer and modulating stress granule formation

Nuclease resistant double-stranded ribonucleic acid

RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)

Methods and compositions for treating prostate cancer

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF BREAST CANCER

Double stranded RNA compounds to RhoA and use thereof

Double-stranded RNA-based nanoparticles for insect gene silencing

LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENT

MLK4 gene, a new diagnostic and prognostic marker in cancers

Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA

Reduced size self-delivering RNAi compounds

Method for inhibiting HIV replication in mammal and human cells

Oligonucleotides comprising acyclic and abasic nucleosides and analogs

SiRNA structure for minimizing off-target effects caused by antisense strands, and use thereof

TARGETED DELIVERY TO LEUKOCYTES USING PROTEIN CARRIERS

HER2 nucleic acid aptamers

Modulation of BCL11A for treatment of hemoglobinopathies

Compositions and methods for silencing apolipoprotein B

Compositions and methods for inhibiting expression of Mylip/Idol gene

Modulation of diacylglycerol acyltransferase 2 expression

Combined use of PRAME inhibitors and HDAC inhibitors

Methods for cancer management targeting Co-029

Cyclic cationic lipids and methods of use

Method for transfecting nucleic acid to cell and nucleic acid complex

METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION

Method of producing lipid nanoparticles for drug delivery

Reducer of immunosuppression by tumor cell and antitumor agent using the same

Baculovirus-mediated transgene expression in both mammalian and insect cells

Cationic lipid

Interfering RNA molecules

RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use

General composition framework for ligand-controlled RNA regulatory systems

Nucleic acid molecules that target RPS6 and confer resistance to coleopteran pests

Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression

UNA oligomers for therapeutics

Methods involving aldose reductase inhibitors

Compositions and methods for treating neurological disorders

Hyaluronic acid decomposition-promoting factor and inhibitor thereof

BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION

Nucleic acid molecules that target RPA70 and confer resistance to coleopteran pests

Nucleic acid molecules that target PP1-87B and confer resistance to coleopteran pests

Agent for suppressing expression of dominant allele

Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase

Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors

Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease

siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions

Double Stranded RNA Constructs to Control Ants

CANCER-SPECIFIC GENETIC REARRANGEMENTS

MICROBUBBLE COMPLEXES AND METHODS OF USE

RNA interference of galectin-3 expression and methods of use thereof

Monoclonal antibodies for treatment of cancer

Mammalian Genes Involved in Tularemia and Other Infections

COLON CANCER TARGETS AND USES THEREOF

MODULATING PRODUCTION TRAITS IN AVIANS

Use of Antisense Oligonucleotides or siRNA to Suppress Expression of eIF-5A1

Modified oligonucleotides for telomerase inhibition

NLK as a marker for diagnosis of liver cancer and as a therapeutic agent thereof

Reverse micelle system comprising nucleic acids and use thereof

Compositions and methods for inhibiting expression of CD45 gene

Nucleic acid-lipopolymer compositions

Double-stranded RNA molecules with stability in mammalian body fluid, preparation and application thereof

Compositions and methods for silencing genes expressed in cancer

SiRNA-mediated gene silencing

METHODS OF INCREASING MACROPINOCYTOSIS IN CANCER CELLS

Compositions and Methods for Inhibiting Viral Replication

Method of rapidly producing improved vaccines for animals

NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof

METHODS AND COMPOSITIONS FOR MAINTENANCE OF A FUNCTIONAL WOUND

Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts

MODULATION OF GLUCOSE-6-PHOSPHATASE TRANSLOCASE EXPRESSION

siRNA Targeting Fructose-1, 6-bisphosphatase 1 (FBP1)

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

Composition and Method for Treatment of Tumors

SINGLE-WALLED CARBON NANOTUBE/BIOACTIVE SUBSTANCE COMPLEXES AND METHODS RELATED THERETO

METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS

COMPOSITIONS AND METHODS FOR PROMOTING FATTY ACID PRODUCTION IN PLANTS

Cationic lipids for oligonucleotide delivery

Modulation of growth hormone receptor expression and insulin-like growth factor expression

Natural antisense and non-coding RNA transcripts as drug targets

Composition For Delivery Of Genetic Material

Monomers and oligonucleotides comprising cycloaddition adduct(s)

Humanized lewis-Y specific antibody-based delivery of dicer substrate siRNA (D-siRNA) against STAT3

Polypeptides having arabinofuranosidase activity and polynucleotides encoding same

COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE

FLT3 receptor antagonists for the treatment or the prevention of pain disorders

Methods of increasing bone mass in a subject comprising inhibiting DKK1

Inhibitors of FAM3B gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals

Double-stranded oligonucleotides

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

AGENT FOR TREATING MYELOFIBROSIS

Methods and compositions to protect aquatic invertebrates from disease

Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

Treatment of metastatic tumors

SIRNA-based therapy of Fibrodyplasia Ossificans Progressiva (FOP)

Isoform of bruton's tyrosine kinase (BTK) protein

ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN

NEW ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN

COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DSRNA CONTAINING MODIFIED NUCLEOTIDES

Recurrent gene fusions in prostate cancer

COMPOSITIONS AND METHODS FOR INHIBITION OF VEGF

Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics

STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES

Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer

Compositions and methods for the control of root lesion nematode

METHOD OF PRODUCING TRANSCRIPTS USING CRYPTIC SPLICE SITES

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

Oligonucleotide compounds comprising non-nucleotide overhangs

Anti-sense oligonucleotides targeted against exon 9 of IL-23Rα gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases

KLF6 ALTERNATIVE SPLICE FORMS AND A GERMLINE KLF6 DNA POLYMORPHISM ASSOCIATED WITH INCREASED CANCER RISK

EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) BINDING REAGENTS AND THEIR THERAPEUTIC USES IN OCULAR DISEASES

MODULATING XRN1

SR-BI mutation as a predictor of low progesterone levels and poor fetal viability during pregnancy

RNAi Modulation Of RSV And Therapeutic Uses Thereof

MODULATION OF TIMP1 AND TIMP2 EXPRESSION

Genetic Inhibition by Double-Stranded RNA

RNAi therapeutic for treatment of Hepatitis C infection

RNAi therapeutic for treatment of hepatitis C infection

PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11 (PTPN11) AND TUMOR INITIATING CELLS

Methods to predict and prevent resistance to taxoid compounds

Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs

Compositions and methods for inhibiting expression of XBP-1 gene

Modulation of angiopoietin-like 3 expression

siRNA for inhibition of c-Met expression and anticancer composition containing the same

Compositions and methods for inhibiting expression of Eg5 and VEGF genes

Methods involving aldose reductase inhibitors

LDL QUANTITATION AND METHOD OF USE

siRNA Targeting Beta Secretase (BACE)

Detecting PAX2 for the diagnosis of breast cancer

Detecting PAX2 for the diagnosis of breast cancer

Fidgetin-like 2 as a target to enhance wound healing

IMMUNE MODULATORS RELATING TO FOXO3A

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

Methods and compositions to modulate antiviral and immune activity responses

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

METHODS OF PRODUCING HYBRIDOMAS AND MONOCLONAL ANTIBODIES AND ANTIBODIES PRODUCED THEREBY

SIRNAS TARGETING EXON 10 OF PYRUVATE KINASE M2

iRNA Agents Targeting VEGF

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Use of siRNA targetting SIPA1L1 for the reduction of adipogenesis

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Method and compositions involving microRNA

OSTEOARTHRITIS BIOMARKERS AND USES THEREOF

Breast Tumor Markers and Methods of Use Thereof

Method for selectively inhibiting the activity of ACAT1 in the treatment of alzheimer's disease

Compounds for targeting drug delivery and enhancing siRNA activity

Chemotherapeutic methods and compositions

Compositions and methods for inhibiting expression of GSK-3 genes

Organic compositions to treat Beta-ENaC-related diseases

GNAQ targeted dsRNA compositions and methods for inhibiting expression

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Compositions and methods for transport across the blood brain barrier

NUCLEIC ACID COMPOUNDS FOR INHIBITING GENE EXPRESSION AND USES THEREOF

Methods for reducing protein levels in a cell

MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF

Protein arginine N-methyltransferase-5 method of cancer treatment

SYSTEM FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS

INACTIVATED MICROORGANISMS CONTAINING DOUBLE -STRAND RNA MOLECULES (DSRNA), THEIR USE AS PESTICIDES AND METHODS FOR THEIR PREPARATION

Methods and sequences to suppress primate Huntington gene expression

Compositions and methods for inhibiting gene expression of hepatitis B virus

RNAi modulation of RSV and therapeutic uses thereof

Ovary tumor markers and methods of use thereof

SMOCI, TENASCIN-C AND BRAIN CANCERS

Influenza targets

Inhibition of P21 and Use Thereof for Inducing Tissue Regeneration

Short hairpin RNAs for inhibition of gene expression

Methods and compositions for reducing viral genome amounts in a target cell

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2

MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

THERAPEUTIC AGENT FOR FIBROID LUNG

Modified siRNA molecules and uses thereof

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

Method of reducing recurrence of multiple sclerosis symptoms in a mammal by administering an anti-repulsive guidance molecule neutralizing antibody

EP1 INHIBITION

Methods for treating and/or limiting development of diabetes

Modulation of Axon Degeneration

Modulation of synaptic maintenance

Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types

Kits comprising linear DNAs for sustained polypeptide expression using synthetic, modified RNAs

Kit for making induced pluripotent stem cells using modified RNAs

Compositions and Methods for Inhibiting Expression of a Mutant Gene

Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells

Duplex oligonucleotide complexes and methods for gene silencing by RNA interference

METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA

Down-regulating gene expression in insect pests

Lung Tumor Markers and Methods of Use Thereof

Compositions and methods for inhibiting expression of the HAMP gene

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

Composition containing inhibitors of the expression or activity of SH3RF2 for preventing or treating cancer

MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS

Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis

RNAi therapeutic for treatment of hepatitis C infection

METHODS AND COMPOSITIONS FOR TREATING INSECTS

Low density lipoprotein receptor-mediated siRNA delivery

Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1

Delivery of dsRNA to arthropods

RNAI IN BUDDING YEAST

COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF HIF-1 ALPHA

METHODS FOR TREATING DISEASES

VEGF-D/VEGFR2/3-MEDIATED REGULATION OF DENDRITES

USE OF GILZ PROTEIN EXPRESSED IN DENDRITIC CELLS TO MODULATE AN ANTIGEN-SPECIFIC IMMUNE RESPONSE

CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

Methods for identifying drug effects on a cell by determining changes in the cell's spliced message profile

LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF

Tetrary gene delivery system for gene therapy and methods of its use

Heparanase splice variant

Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products

RNA interference target for treating AIDS

Plants resistant to insect pests

ZINC-FINGER NUCLEASE AND RNA INTERFERENCE MEDIATED INACTIVATION OF VIRAL GENOMES

Recurrent gene fusions in prostate cancer

AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL

Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1

Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8

TREATMENT OF FILAGGRIN (FLG) RELATED DISEASES BY MODULATION OF FLG EXPRESSION AND ACTIVITY

Microrna-based methods and compositions for the diagnosis, prognosis and treatment of tumor involving chromosomal rearrangements

Recurrent gene fusions in prostate cancer

Prostate carcinogenesis predictor

Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)

Method of predicting and reducing risk of metastasis of breast cancer to lung

MODULATION OF GPCR-MEDIATED CAMP PRODUCTION THROUGH LRP6 AND ITS THERAPEUTIC APPLICATION

Impaired wound healing compositions and treatments

Antibodies that bind polypeptides involved in the process of bone remodeling

Reduction of off-target RNA interference toxicity

Method of inhibiting miR-33 using a modified oligonucleotide

Methods and compositions for regulating RNA import into mitochondria

siRNA Targeting Glucagon Receptor (GCCR)

Sirna compounds comprising terminal substitutions

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

siRNA targeting amyloid beta (A4) precursor protein (APP)

SCREENING METHOD

METHOD FOR THE PREPARATION OF AN INFLUENZA VIRUS

Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes

Cochleate compositions directed against expression of proteins

Bi-specific digoxigenin binding antibodies

ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS

Rhodopsin gene conserved regions in a viral vector enhance expression

Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG

ACTIVITY GENERATING DELIVERY MOLECULES

Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification

CONTROL OF GENE EXPRESSION

NOVEL COMPOUNDS FOR MODULATING NEOVASCULARISATION AND METHODS OF TREATMENT USING THESE COMPOUNDS

Nucleic acid-containing lipid particles and related methods

COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF ICAM-1

Screening methods for compounds that modulate ARF-6 mediated endosomal redistribution

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers

SiRNA targeting apolipoprotein (APOB)

Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer

Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus

siRNA Targeting Diacylglycerol O-Acyltransferase Homolog 2 (DGAT2)

Alternative export pathways for vector expressed RNA interference

Method for analyzing secretome, biomarker for lung cancer metastasis, and siRNA compound for inhibiting lung cancer metastasis

Method of inducing an immune response

ANTI-C MPL ANTIBODIES

Methods for treating chronic obstructive pulmonary disease

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

RNAi-mediated inhibition of histamine receptor H1-related conditions

Method for introducing siRNA into cells by photochemical internalisation

MEDICAMENT FOR THE TREATMENT AND PREVENTION OF LIVER FAILURE